2025年單核苷酸多態性（SNP）基因型鑒定全球市場報告

預計未來幾年單核苷酸多態性 (SNP)基因型鑒定市場將快速成長，到 2029 年將達到 248.9 億美元，複合年成長率為 19.2%。預測期內的成長歸因於疾病研究應用的不斷擴展、精準醫療需求的不斷成長、生物樣本庫項目的不斷擴展、基因檢測的指數級成長以及在農業領域用於作物改良的應用日益增多。預測期內的主要趨勢包括：次世代定序(NGS) 的應用日益普及、藥物基因組學領域對 SNP基因型鑒定的需求日益成長、直接面對消費者的基因檢測的興起、對自動化和高通量基因型鑒定平台的關注。

未來五年19.2%的成長預測比我們先前的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能導致韓國和德國開發的微陣列晶片和TaqMan檢測試劑價格上漲，從而阻礙單核苷酸多態性基因基因型鑒定在美國的大規模應用，導致藥物基因體學檢測延遲和分子診斷成本上升。互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響可能會產生更廣泛的影響。

預計慢性病盛行率的上升將在未來幾年推動單核苷酸多態性 (SNP)基因型鑒定市場的成長。慢性病是指持續時間超過一年、需要持續醫療照護且常常限制日常活動的健康問題。 SNP基因型鑒定在識別遺傳易感性和推進個人化醫療以應對日益成長的慢性病盛行率方面發揮關鍵作用。例如，2024 年 6 月，澳洲政府機構澳洲健康與福利研究所報告稱，與慢性病相關的死亡率從 2021 年的每 10 萬人 459 人上升到 2022 年的每 10 萬人 490 人。因此，慢性病負擔的增加正在推動單核苷酸多態性 (SNP)基因型鑒定系統市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球單核苷酸多態性（SNP）基因型鑒定：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球單核苷酸多態性（SNP）基因型鑒定市場：成長率分析
• 全球單核苷酸多態性 (SNP)基因型鑒定市場表現：規模與成長，2019-2024 年
• 全球單核苷酸多態性 (SNP)基因型鑒定市場預測：規模與成長，2024-2029 年，2034 年
• 全球單核苷酸多態性（SNP）基因型鑒定：總潛在市場（TAM）

第6章 市場細分

• 全球單核苷酸多態性 (SNP)基因型鑒定市場：依產品、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 耗材
• 裝置
• 服務
• 全球單核苷酸多態性 (SNP)基因型鑒定市場：按技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
• TaqMan SNP基因型鑒定
• Mass Array SNP基因型鑒定
• SNP基因晶片陣列
• 其他技術
• 全球單核苷酸多態性 (SNP)基因型鑒定市場：按應用、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
• 動物遺傳學
• 植物改良
• 診斷調查
• 製藥和藥物基因組學
• 農業生物技術
• 其他用途
• 全球單核苷酸多態性 (SNP)基因型鑒定市場：按耗材（產品）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 試劑和套件
• DNA探針
• 微陣列
• 全球單核苷酸多態性 (SNP)基因型鑒定市場：按儀器（產品）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• SNP基因型鑒定平台
• 序列器
• PCR儀
• 全球單核苷酸多態性 (SNP)基因型鑒定市場：按服務（產品）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• SNP基因型鑒定服務
• 數據分析服務
• 諮詢服務

第7章 區域和國家分析

• 全球單核苷酸多態性 (SNP)基因型鑒定市場：按地區、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
• 全球單核苷酸多態性 (SNP)基因型鑒定市場：按國家/地區、實際結果和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 單核苷酸多態性（SNP）基因型鑒定市場：競爭格局
• 單核苷酸多態性（SNP）基因型鑒定市場：公司簡介
  • Thermo Fischer Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Genomics LLC Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Qiagen NV
• Sigma-Aldrich Corporation
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Illumina Inc.
• Promega Corporation
• GenScript Biotech Corporation
• Integrated DNA Technologies Inc.
• LGC Ltd.
• Sequenom Inc.
• Fluidigm Corporation
• Agendia Inc.
• Nugen Technologies Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029年單核苷酸多態性（SNP）基因型鑒定市場：提供新機會的國家
• 2029年單核苷酸多態性（SNP）基因型鑒定市場：細分領域帶來新機會
• 2029年單核苷酸多態性（SNP）基因型鑒定市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Single nucleotide polymorphism (SNP) genotyping is a procedure that identifies and describes genetic variants at the level of specific DNA nucleotides. It focuses on pinpointing individual SNPs, which are single-base changes in DNA sequences. This process is crucial for gaining insights into genetic variations associated with diseases, traits, and population studies.

The primary products of single nucleotide polymorphism (SNP) genotyping include consumables, instruments, and services. Consumables refer to items that people and businesses regularly consume or use up, requiring replacement, such as food and home supplies. Various technologies are employed in SNP genotyping, including TaqMan SNP genotyping, Mass Array SNP genotyping, SNP gene chip arrays, and others. These technologies find applications in diverse fields such as animal genetics, plant improvement, diagnostic research, pharmaceuticals and pharmacogenomics, agricultural biotechnology, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The single nucleotide polymorphism (SNP) genotyping market research report is one of a series of new reports from The Business Research Company that provides single nucleotide polymorphism (SNP) genotyping market statistics, including the single nucleotide polymorphism (SNP) genotyping industry's global market size, regional shares, competitors with a single nucleotide polymorphism (SNP) genotyping market share, detailed single nucleotide polymorphism (SNP) genotyping market segments, market trends and opportunities, and any further data you may need to thrive in the single nucleotide polymorphism (SNP) genotyping industry. This single nucleotide polymorphism (SNP) genotyping market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The single nucleotide polymorphism (snp) genotyping market size has grown rapidly in recent years. It will grow from $10.3 billion in 2024 to $12.34 billion in 2025 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to increasing research in genomics, rise in genetic disorders, growth in personalized medicine, expanding pharmaceutical industry, and rising demand for molecular diagnostics.

The single nucleotide polymorphism (snp) genotyping market size is expected to see rapid growth in the next few years. It will grow to $24.89 billion in 2029 at a compound annual growth rate (CAGR) of 19.2%. The growth in the forecast period can be attributed to growing applications in disease research, a rise in demand for precision medicine, expanding biobanking initiatives, the surge in genetic testing, and rising adoption in agriculture for crop improvement. Major trends in the forecast period include increasing use of next-generation sequencing (NGS), rising demand for SNP genotyping in pharmacogenomics, the emergence of direct-to-consumer genetic testing, focus on automation, and high-throughput genotyping platforms.

The forecast of 19.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of large-scale Single Nucleotide Polymorphism genotyping by inflating prices of microarray chips and TaqMan assays developed in South Korea and Germany, resulting in slower pharmacogenomic testing and higher molecular diagnostics costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic conditions is anticipated to drive the growth of the single nucleotide polymorphism (SNP) genotyping market in the coming years. Chronic conditions are health issues that persist for a year or longer, requiring ongoing medical care and often limiting daily activities. SNP genotyping plays a crucial role in identifying genetic predispositions and advancing personalized medicine in response to the growing prevalence of chronic diseases. For example, in June 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that the death rate associated with chronic conditions increased from 459 deaths per 100,000 people in 2021 to 490 deaths per 100,000 people in 2022. Consequently, the increasing burden of chronic conditions is driving the growth of the single nucleotide polymorphism (SNP) genotyping systems market.

The increasing funding for genomic research is expected to drive the growth of the single nucleotide polymorphism (SNP) genotyping market in the future. Funding for genomic research refers to the financial resources allocated, granted, or invested to support activities in the field of genomics. Such funding is crucial for advancing SNP studies by facilitating various research initiatives, technology development, and collaborative projects. For instance, in September 2024, the National Institutes of Health (NIH), a US-based government agency, announced the allocation of $27 million to establish a new network of genomics-enabled learning health systems. Therefore, the rise in funding for genomic research is propelling the growth of the single nucleotide polymorphism (SNP) genotyping market.

A prominent trend in the single nucleotide polymorphism (SNP) genotyping market is the adoption of technological solutions. Major companies in this market are introducing advanced solutions to maintain their market position. For instance, in May 2022, Neogen Corporation and Gencove launched InfiniSEEK, the first complete genome and genotyping tool for cattle breeders. InfiniSEEK's validation demonstrates high concordance with deep whole-genome sequencing, providing clinical-grade accuracy in specific areas of interest. This technological advancement underscores the commitment of companies to bring innovative solutions to the single nucleotide polymorphism (SNP) genotyping market.

Companies in the single nucleotide polymorphism (SNP) genotyping market are also focusing on developing biomarkers for coronary heart disease detection, enhancing market profitability. Single nucleotide polymorphism (SNP) biomarkers associated with coronary heart disease (CHD) detection are genetic variations linked to an increased risk of CHD. For instance, Cardio Diagnostics launched PrecisionCHD in February 2023, an AI-driven blood test utilizing epigenetic and genetic biomarkers to detect CHD. This non-invasive test eliminates the need for traditional methods, providing objectivity through biomarkers rather than self-reported patient data.

In December 2023, Neogen Corporation, a US-based food safety company known for its diverse genomic technologies, particularly in single nucleotide polymorphism (SNP) genotyping, formed a partnership with TerraNova Equestrian Center. This collaboration aims to strengthen biosecurity measures at TerraNova Equestrian Center by implementing Neogen's advanced cleaning and disinfectant solutions. The focus is on protecting the health of horses and their owners while fostering a safe environment for equestrian competitions. TerraNova Equestrian Center is a US-based facility that offers premier services for riders and horses.

Major companies operating in the single nucleotide polymorphism (SNP) genotyping market include Thermo Fischer Scientific Inc., Danaher Corporation, Roche Diagnostics Corporation, GE HealthCare Technologies Inc., Eurofins Genomics LLC, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Sigma-Aldrich Corporation, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Promega Corporation, GenScript Biotech Corporation, Integrated DNA Technologies Inc., LGC Ltd., Sequenom Inc., Fluidigm Corporation, Agendia Inc., Nugen Technologies Inc., BioChain Institute Inc., Standard BioTools Inc., Oxford Gene Technology, Affymetrix Inc., PREMIER Biosoft International Inc., GenoLogics, Rubicon Genomics Inc., Xcelris Genomics, Douglas Scientific LLC, Golden Helix Inc.

North America was the largest region in the single nucleotide polymorphism (SNP) genotyping market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single nucleotide polymorphism (snp) genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the single nucleotide polymorphism (snp) genotyping market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The single nucleotide polymorphism (SNP) genotyping market includes revenues earned by providing sample collection, DNA extraction, high-resolution melting analysis, and related next-generation sequencing. The market value includes the value of related goods sold by the service provider or included within the service offering. The single nucleotide polymorphism (SNP) genotyping market consists of sales of mass spectrometry-based SNP genotyping and allele-specific PCR. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single Nucleotide Polymorphism (SNP) Genotyping Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on single nucleotide polymorphism (snp) genotyping market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for single nucleotide polymorphism (snp) genotyping ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single nucleotide polymorphism (snp) genotyping market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Consumables; Instruments; Services
• 2) By Technology: TaqMan SNP Genotyping; Mass Array SNP Genotyping; SNP Gene Chip Arrays; Other Technologies
• 3) By Application: Animal Genetics; Plant Improvement; Diagnostic Research; Pharmaceuticals And Pharmacogenomics; Agricultural Biotechnology; Other Applications
• Subsegments:
• 1) By Consumables: Reagents And Kits; DNA Probes; Microarrays
• 2) By Instruments: SNP Genotyping Platforms; Sequencers; PCR Machines
• 3) By Services: SNP Genotyping Services; Data Analysis Services; Consultation Services
• Companies Mentioned: Thermo Fischer Scientific Inc.; Danaher Corporation; Roche Diagnostics Corporation; GE HealthCare Technologies Inc.; Eurofins Genomics LLC; Beckman Coulter Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Sigma-Aldrich Corporation; Agilent Technologies Inc.; PerkinElmer Inc.; Illumina Inc.; Promega Corporation; GenScript Biotech Corporation; Integrated DNA Technologies Inc.; LGC Ltd.; Sequenom Inc.; Fluidigm Corporation; Agendia Inc.; Nugen Technologies Inc.; BioChain Institute Inc.; Standard BioTools Inc.; Oxford Gene Technology; Affymetrix Inc.; PREMIER Biosoft International Inc.; GenoLogics; Rubicon Genomics Inc.; Xcelris Genomics; Douglas Scientific LLC; Golden Helix Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Single Nucleotide Polymorphism (SNP) Genotyping Market Characteristics

3. Single Nucleotide Polymorphism (SNP) Genotyping Market Trends And Strategies

4. Single Nucleotide Polymorphism (SNP) Genotyping Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Single Nucleotide Polymorphism (SNP) Genotyping Growth Analysis And Strategic Analysis Framework

• 5.1. Global Single Nucleotide Polymorphism (SNP) Genotyping PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth Rate Analysis
• 5.4. Global Single Nucleotide Polymorphism (SNP) Genotyping Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Single Nucleotide Polymorphism (SNP) Genotyping Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Single Nucleotide Polymorphism (SNP) Genotyping Total Addressable Market (TAM)

6. Single Nucleotide Polymorphism (SNP) Genotyping Market Segmentation

• 6.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consumables
• Instruments
• Services
• 6.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• TaqMan SNP Genotyping
• Mass Array SNP Genotyping
• SNP Gene Chip Arrays
• Other Technologies
• 6.3. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Animal Genetics
• Plant Improvement
• Diagnostic Research
• Pharmaceuticals And Pharmacogenomics
• Agricultural Biotechnology
• Other Applications
• 6.4. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• DNA Probes
• Microarrays
• 6.5. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• SNP Genotyping Platforms
• Sequencers
• PCR Machines
• 6.6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• SNP Genotyping Services
• Data Analysis Services
• Consultation Services

7. Single Nucleotide Polymorphism (SNP) Genotyping Market Regional And Country Analysis

• 7.1. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market

• 8.1. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Single Nucleotide Polymorphism (SNP) Genotyping Market

• 9.1. China Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 9.2. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Single Nucleotide Polymorphism (SNP) Genotyping Market

• 10.1. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market

• 11.1. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 11.2. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market

• 12.1. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market

• 13.1. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market

• 14.1. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 14.2. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market

• 15.1. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 15.2. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Single Nucleotide Polymorphism (SNP) Genotyping Market

• 16.1. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market

• 17.1. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Single Nucleotide Polymorphism (SNP) Genotyping Market

• 18.1. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market

• 19.1. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market

• 20.1. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market

• 21.1. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 21.2. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market

• 22.1. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Single Nucleotide Polymorphism (SNP) Genotyping Market

• 23.1. North America Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 23.2. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Single Nucleotide Polymorphism (SNP) Genotyping Market

• 24.1. USA Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 24.2. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market

• 25.1. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 25.2. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Single Nucleotide Polymorphism (SNP) Genotyping Market

• 26.1. South America Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 26.2. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market

• 27.1. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market

• 28.1. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 28.2. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market

• 29.1. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
• 29.2. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Single Nucleotide Polymorphism (SNP) Genotyping Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Landscape And Company Profiles

• 30.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Landscape
• 30.2. Single Nucleotide Polymorphism (SNP) Genotyping Market Company Profiles
  • 30.2.1. Thermo Fischer Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eurofins Genomics LLC Overview, Products and Services, Strategy and Financial Analysis

31. Single Nucleotide Polymorphism (SNP) Genotyping Market Other Major And Innovative Companies

• 31.1. Beckman Coulter Inc.
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. Qiagen N.V.
• 31.4. Sigma-Aldrich Corporation
• 31.5. Agilent Technologies Inc.
• 31.6. PerkinElmer Inc.
• 31.7. Illumina Inc.
• 31.8. Promega Corporation
• 31.9. GenScript Biotech Corporation
• 31.10. Integrated DNA Technologies Inc.
• 31.11. LGC Ltd.
• 31.12. Sequenom Inc.
• 31.13. Fluidigm Corporation
• 31.14. Agendia Inc.
• 31.15. Nugen Technologies Inc.

32. Global Single Nucleotide Polymorphism (SNP) Genotyping Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Single Nucleotide Polymorphism (SNP) Genotyping Market

34. Recent Developments In The Single Nucleotide Polymorphism (SNP) Genotyping Market

35. Single Nucleotide Polymorphism (SNP) Genotyping Market High Potential Countries, Segments and Strategies

• 35.1 Single Nucleotide Polymorphism (SNP) Genotyping Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Single Nucleotide Polymorphism (SNP) Genotyping Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Single Nucleotide Polymorphism (SNP) Genotyping Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer